skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
01/14/1997
Application #:
08163186
Filing Dt:
12/07/1993
Inventors:
QING S. ZENG, REIKO F. IRIE
Title:
IGG DEPLETED SERUM PREPARATIONS AND METHODS FOR ANTIBODY PRODUCTION
Assignment: 1
Reel/Frame:
006863/0604Recorded: 02/14/1994Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
02/02/1994
Exec Dt:
02/02/1994
Assignee:
2200 SANTA MONICA BLVD.
SANTA MONICA, CALIFORNIA 90404
Correspondent:
DAVID L. PARKER, ESQ.
ARNOLD, WHITE & DURKEE
P.O. BOX 4433
HOUSTON, TX 77210
Assignment: 2
Reel/Frame:
008026/0633Recorded: 05/17/1996Pages: 8
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
03/14/1996
Assignee:
EXTRAMURAL INVENTIONS OFFICES, THE MSC 7750
6701 ROCKLEDGE DRIVE, ROOM 3188
BETHESDA, MARYLAND 20892
Correspondent:
NATIONAL INSTITUTES OF HEALTH, THE
BELEN AWETAHEGNE
EXTRAMURAL INVENTIONS OFFICE, THE
6701 ROCKLEDGE DRIVE, RM 3188, MSC 7750
BETHESDA, MARYLAND / USA 20892-7750
Assignment: 3
Reel/Frame:
021254/0114Recorded: 07/17/2008Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
03/14/1996
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980

Search Results as of: 05/06/2024 09:02 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT